UPDF AI

Infectious Diseases: Safety Concerns with Fluoroquinolones

Allana J Mehlhorn,Dana A. Brown

2007 · DOI: 10.1345/aph.1K347
The Annals of Pharmacotherapy · 130 Citations

TLDR

Clinicians should be aware of possible alterations in blood glucose, QTc interval prolongation, seizures, phototoxicity, tendinopathy, or CDAD with the use of any fluoroquinolone, especially in patients with other risk factors for these conditions.